A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their ...
Hosted on MSN
GSK’s new study on belantamab mafodotin: A potential game-changer for multiple myeloma treatment
GlaxoSmithKline (GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has announced a new clinical study titled ‘A Phase 2, Multicenter, Open Label, Non-randomized Study to ...
The Galleri-Medicare study called REACH (Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity) is a non-randomized, observational study of 50,000 Medicare beneficiaries. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results